COLPALFast Moving Consumer Goods

Colgate Palmolive (India) Limited

Personal Care · ISIN INE259A01022 · BSE 500830 · NSE EQ · FV ₹1
Last price
₹1,840
-1.06%today
What this company does

Colgate Palmolive (India) Limited operates in Personal Care, part of the Fast Moving Consumer Goods sector. It booked ₹1,603 cr of revenue in its latest quarter (Q1 FY27) and kept 21.4% of sales as profit. It is the 3rd largest of 9 Personal Care companies we track, by market value.

Their stated mission

is to deliver Pradesh high-quality products that consistently meet and exceed consumer expectations through manufacturing excellence.

In the report:
77out of 100
Equitytale Health Score
Solid

Healthier than 77% of companies in Fast Moving Consumer Goods, on all six measures of filed financials. Each measure is ranked against the 89–149 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
neutral
RSI (14)
42

At close. Not part of the score.

Profitability & returns98

How much profit it earns on the money it employs · highest in its sector on what we could measure

Balance sheet89

How much it owes, and whether earnings cover the interest

Cash quality77

Whether reported profit actually arrives as cash

Growth & consistency59

Whether sales and profit have grown, and how steadily

Valuation25

What today's price implies, against our models or its peers

Governance & risk100

How much of the promoters' stake is pledged, and how much they hold · highest in its sector on what we could measure

Is this company doing well?
not investment advice
Looks broadly healthyPriced in line with peers
Strengths
Makes a profit
Strong 21% net margin
Sales up 12% vs last year
Profit up 7% vs last year
Promoters hold 51%
No promoter shares pledged
Strong 87% return on equity
Virtually debt-free
Turns profit into real cash
Watch-outs
None flagged from our data

What if I invest in COLPAL?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 4% a year, it would become
₹14.72 lakh

The slider starts at 4%, taken from this company's own free-cash-flow trend. That is history, not a forecast — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest quarter + price
₹1,840 -1.06%
latest close · 2026-09-17
1-year return
+11.2%
52-wk low ₹1,37652-wk high ₹2,213
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/E ratio36.5High
LowAverageHigh
P/B ratio31.60High
Below bookModerateHigh
EV / EBITDA24.2High
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity86.6%Strong
WeakFairStrong ▸15%
Return on capital111.3%Strong
WeakFairStrong
Net margin21.4%Strong
ThinDecentStrong
EBITDA margin31.3%Healthy
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.00Comfortable
LowModerateHigh ▸1
Interest cover449.7×Strong
RiskyOkayStrong ▸5×
Current ratio1.28Healthy
Tight ◂1HealthyAmple
More figures
Market cap
₹50,056 cr
Book value
₹58
EPS
₹12.61
latest quarter
Net debt
₹-1,426 cr
more cash than debt
Enterprise value
₹48,630 cr
EBITDA
₹2,010 cr
annualised
EBIT
₹1,853 cr
annualised
Operating margin
28.9%
Return on assets
40.3%
Earnings yield
2.74%
P/S
7.81
Sales / share
₹235.8
Tax rate
25.8%
Face value
₹1
Shares
27.2 cr
Working capital
₹488 cr
Current assets
₹2,231 cr
Current liabilities
₹1,743 cr
Delivery %
57.7%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are annualised from the latest quarter; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-09-17.

Worth vs price · from the FY 2026 report & filings
not investment advice
Hard to value confidentlyLow confidence
The market price is far above what these earnings- and book-based models support — a fast-growing or asset-light business can trade well above them for years, so we won't put a confident number on how overpriced it is.
Models span ₹634₹834, midpoint ₹734

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · Q1 FY27 (consolidated)
Revenue from Operations₹1,603 cr
Other Income₹23 cr
Total Income₹1,626 cr
Cost of Materials₹433 cr
Purchases of Stock-in-Trade₹90 cr
Inventory Change (±)₹-41 cr
Employee Benefit Expense₹129 cr
Finance Costs₹1 cr
Depreciation & Amortisation₹39 cr
Other Expenses₹510 cr
Total Expenses₹1,161 cr
Exceptional Items₹-3 cr
Profit before Tax₹462 cr
Tax Expense₹119 cr
Net Profit₹343 cr
Net margin on total income21.1%
Where the money goes · Q1 FY27
% of total income
Materials + stock-in-trade₹482 cr29.7%
Employee benefit expense₹129 cr8.0%
Finance costs₹1 cr0.1%
Depreciation & amortisation₹39 cr2.4%
Other expenses₹510 cr31.4%
Tax expense₹119 cr7.3%
Profit for the period₹343 cr21.1%
Total income ₹1,626 cradds up to ₹100 ✓
Quarterly results · consolidated (₹ cr)
MetricQ3 FY26Q4 FY26Q1 FY27
Revenue1,486 cr1,595 cr1,603 cr
Total income1,525 cr1,612 cr1,626 cr
Expenses1,081 cr1,122 cr1,161 cr
Profit before tax436 cr474 cr462 cr
Tax112 cr121 cr119 cr
Net profit (owners' share)324 cr353 cr343 cr
Net margin (owners' share, on revenue)21.8%22.1%21.4%
EPS (₹)11.9112.9912.61
YoY (latest quarter): total income +12.0% · net profit +7.0%
Balance sheet & cash flow · as of Mar 2026
Debt-free
Total assets
₹3,408 cr
Shareholder equity
₹1,584 cr
parent shareholders
Total debt
₹0 cr
Cash
₹1,426 cr
Cash flow · H1 FY26
Operating
₹997 cr
Investing
₹381 cr
Financing
₹-740 cr
Peer comparison
Personal Care · by market value
CompanyPriceMarket capP/E
Godrej Consumer Products Limited₹873₹89,325 cr44.3
Dabur India Limited₹385₹68,219 cr28.9
Colgate Palmolive (India) Limitedthis company₹1,840₹50,056 cr36.5
Cupid Limited₹279₹37,536 cr211.5
Procter & Gamble Hygiene and Health Care Limited₹7,613₹24,712 cr48.9
Gillette India Limited₹7,307₹23,814 cr37.3
Emami Limited₹376₹16,417 cr29.8
Honasa Consumer Limited₹460₹15,024 cr41.5
Bajaj Consumer Care Limited₹502₹6,563 cr23.2
Same industry · latest reported numbers · not a recommendation.
Corporate actions
Dividend yield
2.61%
trailing 12 months
Dividend / share (TTM)
₹48
Last dividend
₹24
ex 1 Jun 2026
ActionDetailEx-date
Dividend₹24 / share1 Jun 2026
Dividend₹24 / share3 Nov 2025
Dividend₹27 / share28 May 2025
Dividend₹24 / share4 Nov 2024
Dividend₹10 / share22 May 2024
Dividend₹26 / share22 May 2024
Who owns it · 2026-06-30
No pledge
Promoter
51.0%
FII / Foreign
13.6%
DII / Domestic
15.8%
Retail / others
19.6%
Smart-money activity
Bulk / block deals
short · NSE531 Aug 26
short · NSE27526 Aug 26
short · NSE55524 Aug 26
Stake changes
BoughtLife Insurance Corporation of India→ 5.00% · 50,00012 May 26
SoldMitsubishi UFJ Financial Group (MUFG)→ 2.98% · 54.89 L25 Jul 25
BoughtMitsubishi UFJ Financial Group, Inc. alongwith PAC→ 5.00% · 23,5155 Apr 23
What shareholders were asked to approve

A company cannot decide everything on its own. Things like a top executive’s pay, issuing new shares, or re-appointing a director have to be put to the people who own the company, and they vote — one vote per share. So whoever owns the most shares has the most say.

Yearly shareholder meeting · 22 Jul 2025
See the official result
1
To consider and adopt the Audited Financial Statements of the Company for the Financial Year ended March 31, 2025 and the Reports of the Board of Directors and Auditors thereon.
Backed by 99% of shareholders other than promotersneeded 50%
7.12 cr votes for, 5.94 L against · 1% of mutual funds and other big investors said no
2
To appoint a Director in place of Mr. Jacob Sebastian Madukkakuzy (DIN: 07645510), who retires by rotation and, being eligible, offers himself for re-appointment.
Backed by 99% of shareholders other than promotersneeded 50%
7.18 cr votes for, 5.33 L against · 1% of mutual funds and other big investors said no
3
To approve the appointment of M/s. Dholakia & Associates LLP, as the Secretarial Auditors of the Company.
Backed by 100% of shareholders other than promotersneeded 50%
7.23 cr votes for, 3,871 against · 0% of mutual funds and other big investors said no
4
Payment of Commission to the Non-Executive, Independent Directors of the Company.
Backed by 99% of shareholders other than promotersneeded 75%
7.19 cr votes for, 4.26 L against · 1% of mutual funds and other big investors said no

Every vote count above is taken from the result the company filed with the stock exchange, certified by an independent counter. To work out what would have happened without the promoters, we simply remove their votes and re-apply the same legal bar the proposal had to clear. Nothing here is an estimate or an opinion.

Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 3 named members
owning 51.0% between them · as of 2026-06-30
Colgate-Palmolive Company40.06%
Colgate-Palmolive (Asia) Pte Ltd10.94%
Norwood International Incorporatedno shares

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.